Today: 21 June 2026
Capital One stock drops again as Trump’s credit-card rate-cap talk shadows lenders
14 January 2026
2 mins read

Capital One stock drops again as Trump’s credit-card rate-cap talk shadows lenders

NEW YORK, Jan 14, 2026, 12:12 ET — During the regular session

  • Shares of Capital One dropped roughly 2.4% in midday trading, adding to a turbulent week for credit card issuers
  • Trump’s plan to cap credit-card rates at 10% keeps investors fixated on policy risks rather than earnings season
  • A federal judge has granted preliminary approval for a revised $425 million settlement involving Capital One savings accounts

Shares of Capital One Financial Corp dropped roughly 2.4% to $225.95 on Wednesday, lagging behind as investors grew cautious amid Washington’s discussions on limiting credit-card interest rates.

The pressure stems from President Donald Trump’s proposal to cap credit-card interest rates at 10% for one year—a move that could severely dent a key profit source for issuers if enacted. Credit-card rates were running around 20.97% in November, based on the Federal Reserve’s consumer credit report referenced by analysts.

The timing couldn’t be more awkward. Despite big U.S. banks rolling out their quarterly results, shares slipped, dragging the broader market down as traders mulled over earnings and policy uncertainties. “Banks have had a very strong start to the year and markets are taking a little time to digest” the results, said Jake Johnston, deputy CIO at Advisors Asset Management. Reuters

The selling wasn’t limited to one stock. Synchrony Financial dropped roughly 3.0%, Bread Financial slid about 2.5%, and American Express declined around 1.4% by midday trading.

The driving worry is straightforward: caps on card fees might tighten lenders’ margins, particularly in unsecured credit, potentially leading to tougher approval standards. “It would be very bad for consumers, very bad for the economy,” JPMorgan CFO Jeremy Barnum said Tuesday, cautioning that such limits could reduce credit availability. Reuters

Executives are pushing back against hopes that the headline will turn into swift legislation. Citi CFO Mark Mason told Reuters it’s too early to judge without more details and added, “an interest rate cap is not something that we would or could support.” Reuters

Capital One found itself under the spotlight again. A federal judge in California gave the green light to a revised $425 million class-action settlement tied to the bank’s “360 Savings” accounts. Plaintiffs had accused Capital One of misleading customers when it rolled out the higher-yield “360 Performance Savings” product. “This is a great result for the class,” said lawyer Philip Black. Reuters

The key question for the stock remains unchanged since Monday: will the rate-cap idea falter in Congress, or gain enough traction to push banks to rethink card lending and pricing? If the proposal is watered down or quietly shelved, that would ease near-term pressure. But a serious legislative effort would keep the sector on edge.

Capital One’s next major event is set for next week. The company will report its fourth-quarter 2025 results around 4:05 p.m. ET on Jan. 22, with a conference call scheduled for 5:00 p.m. ET.

Investors remain focused on fresh signals from Washington about how a cap might be implemented. They’re also awaiting Capital One’s update on Jan. 22 regarding card pricing, credit trends, and regulatory costs.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Top 3 FTSE Shares for Beginner Investors to Buy in 2026
    June 21, 2026, 3:05 AM EDT. AstraZeneca, RELX, and another leading FTSE stock stand out as strong picks for beginner investors in 2026. AstraZeneca, a global pharmaceutical giant, boasts a 'best in class' drug pipeline with a raised price target of 16,500p by Bank of America, highlighting potential sales growth despite risks from clinical trial outcomes. RELX, an information analytics provider embedding AI into its platforms, is seen as a 'mis-priced AI beneficiary' with shares trading below historical multiples after a tough 2025. These companies offer durable moats and growth prospects, but investors should weigh optimisms against inherent risks like clinical failures and AI adoption speed.

Latest articles

Home Depot shares finish week up as investors weigh housing numbers

Home Depot shares finish week up as investors weigh housing numbers

21 June 2026
Home Depot jumped 2.1% to $334.28 in a shortened week as Wall Street rallied, but weak U.S. housing starts and upcoming May new-home-sales data keep pressure on the home-improvement outlook; the company reaffirmed 2026 sales and earnings targets despite volatile conditions and persistent housing affordability concerns.
Bitmine (BMNR) stock jumps as Tom Lee pushes last-minute vote on share plan
Previous Story

Bitmine (BMNR) stock jumps as Tom Lee pushes last-minute vote on share plan

DAX record streak snaps as Frankfurt stocks slide; Bayer jumps 7%
Next Story

DAX record streak snaps as Frankfurt stocks slide; Bayer jumps 7%

Go toTop